Nanotechnology Now - Press Release: New Study Titled Drug Delivery Systems Estimates That the US Drug Delivery Market Value Might Reach Nearly $85 Billion By 2010

Home > Press > New Study Titled Drug Delivery Systems Estimates That the US Drug Delivery Market Value Might Reach Nearly $85 Billion By 2010

Abstract:
Research and Markets ( http://www.researchandmarkets.com/reports/c51601 ) has announced the addition of Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices to their offering.

New Study Titled Drug Delivery Systems Estimates That the US Drug Delivery Market Value Might Reach Nearly $85 Billion By 2010

DUBLIN, Ireland | Posted on March 6th, 2007

This research study is about drug delivery systems. It provides readers with relevant information, insights and analysis. This important medical opportunity is assessed in terms of technical and business areas. The participating companies are mapped to show where they fit in the industry landscape. This study reviews the kinds of drug delivery systems that are being used by pharma, biotech or medical device companies.

The report discusses the broad range of drug delivery systems, the technical advances and the applications that drug makers might use. Key advances include orally dissolving tablets and filmstrips, needle- and needle-free injection systems, transdermal patches, transmucosal delivery, RNAi, drug-coated stents, PEG, nanotechnology, liposomes, monoclonal antibodies, gene delivery, and implants, which all contribute to the many ways that drugs or therapies can be delivered. Drug delivery systems are reviewed in terms of approaches used for delivering drugs targeting major diseases including cardiovascular, cancer, asthma, diabetes, and the central nervous system among others.

This market study shows that drug delivery technologies can help drug makers overcome some of their big challenges. The drug industry continues to see the commercial demise of major branded drugs that reach their patent expiration date. Billions of dollars in revenues are lost to generic drug makers each year. The technology can be used as part of a ‘line extension' strategy to extend the commercial life of their profitable products. Drug delivery can help ‘rescue' drug projects with technical challenges by using a customized delivery system.

This report discusses the above topics with interesting and useful findings. The study estimates that the US drug delivery market value might reach nearly $85 billion by 2010. The research includes over 235 key alliances and M&As through 2006. This study uses 29 figures and tables to illustrate the findings or trends. The profiles about companies important to the expanding drug delivery market include detailed information about their business and technical activities.

This report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.

Content Outline:

1.Introduction

2.Drug Delivery Technology Developments

3.Survey of Changing DDS Developments

4.Recent Strategic Alliances and M&As

5.Drug Delivery Systems Market Forecast

6.Patent Litigation Examples

7.Drug Delivery With Nanotechnology

8.Appendices

Appendix A: Top Drug Delivery Companies

Appendix B: Drug Delivery Industry Websites

Pharmaceutical Industry Sites

Government Office Sites

Industry News Sites

Appendix C: Glossary of Terms

About the Publisher and Authors

About Takeda Pacific

About the Authors

List of Tables

List of Illustrations

Companies Mentioned:

-Abgenix, Inc. (Amgen)

-Alkermes, Inc.

-Alnylam Pharmaceuticals, Inc.

-Antigenics, Inc.

-Aradigm Corporation

-Cima Laboratories (Cephalon)

-Elan Corporation

-Intradigm Corporation

-Medarex, Inc.

-NanoBio Corporation

-NanoMed Pharmaceuticals, Inc.

-Nastech Pharmaceutical Company, Inc.

-Nektar Therapeutics

-Nexmed, Inc.

-Noven Pharmaceuticals, Inc.

-Palatin Technologies, Inc.

-Raven Biotechnologies, Inc.

-Sanofi Pasteur SA (Vaccines)

-Sirna Therapeutics, Inc.

-Skyepharma PLC

-Sontra Medical Corporation

-Watson Pharmaceuticals, Inc.

-Wyeth

####

About Research and Markets
We are the leading source for international market research and market data. We hold ‘000’s of major research publications from most of the leading publishers, consultants and analysts. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends

We are a ‘One-Stop-Shop’ for market research reports and industry newsletters from specialist research firms and niche market analysts.

For more information, please click here

Contacts:
Research and Markets
Laura Wood
Senior Manager

Fax: +353 1 4100 980

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: